Efficacy and safety of high dose (≥ 8 mg/kg/day) daptomycin

被引:10
|
作者
Parra-Ruiz, Jorge [1 ]
Pena-Monje, Alejandro [2 ]
Tomas-Jimenez, Cristina [1 ,3 ]
Pomares-Mora, Jose [4 ]
Hernandez-Quero, Jose [1 ]
机构
[1] Hosp Univ San Cecilio, Unidad Enfermedades Infecciosas, Granada, Spain
[2] Hosp Univ San Cecilio, Microbiol Serv, Granada, Spain
[3] Hosp Univ Reina Sofia, Med Interna Serv, Murcia, Spain
[4] Hosp Univ San Cecilia, Serv Med Intens, Granada, Spain
来源
关键词
High dose daptomycin; Efficacy; Safety; SERUM;
D O I
10.1016/j.eimc.2011.02.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: There is a paucity of data regarding efficacy and safety of high dose (> 8 mg/kg/day) daptomycin. Material and methods: This ambispective study included all patients that received >= 8 mg/kg/day of daptomycin and had efficacy and safety data. Results: Sixty-nine patients were included. Fifty-nine patients (85.5%) were recorded as having been cured or improved. Six patients (8.6%) had a raised CPK during follow-up with no clinical signs of myopathy in any of them. Conclusions: High dose daptomycin shows good efficacy without concerns about toxicity. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:425 / 427
页数:3
相关论文
共 50 条
  • [31] Comparative Analysis of Hematological Parameters in Indian Sickle Cell Anemia Patients Treated with Low Dose (10mg/kg/day) Versus Standard Dose (20mg/kg/day) Hydroxyurea
    Khargekar, Naveen
    Madkaikar, Manisha
    Kargutkar, Neha
    Banerjee, Anindita
    Mahajan, Namrata
    Gupta, Kalpna
    BLOOD, 2023, 142
  • [32] Neoadjuvant ipilimumab (3mg/kg or 10mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
    Tarhini, Ahmad
    Lin, Yan
    Lin, Huang
    Rahman, Zahra
    Vallabhaneni, Priyanka
    Mendiratta, Prateek
    Pingpank, James F.
    Holtzman, Matthew P.
    Yusko, Erik C.
    Rytlewski, Julie A.
    Rao, Uma N. M.
    Ferris, Robert L.
    Kirkwood, John M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [33] Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis
    Schindler, Adolf E.
    Henkel, Alexandra
    Moore, Claudia
    Oettel, Michael
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 282 (05) : 507 - 514
  • [34] Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis
    Adolf E. Schindler
    Alexandra Henkel
    Claudia Moore
    Michael Oettel
    Archives of Gynecology and Obstetrics, 2010, 282 : 507 - 514
  • [35] Treatment of American cutaneous Leishmaniasis: A comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens
    OliveiraNeto, MP
    Schubach, A
    Mattos, M
    GoncalvesCosta, SC
    Pirmez, C
    PATHOLOGIE BIOLOGIE, 1997, 45 (06): : 496 - 499
  • [36] INTRAVITREAL DAPTOMYCIN A Safety and Efficacy Study
    Comer, Grant M.
    Miller, John B.
    Schneider, Eric W.
    Khan, Naheed W.
    Reed, David M.
    Elner, Victor M.
    Zacks, David N.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1199 - 1206
  • [37] Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients
    Stein, EA
    Davidson, MH
    Dobs, AS
    Schrott, H
    Dujovne, CA
    Bays, H
    Weiss, SR
    Melino, MR
    Stepanavage, ME
    Mitchel, YB
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (03): : 311 - 316
  • [38] Efficacy and safety of duloxetine 120 mg/day in the treatment of depression
    Goldstein, DJ
    Mallinckrodt, C
    Lu, Y
    Detke, M
    Demitrack, MA
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 108 - 108
  • [39] Efficacy and Safety of Milnacipran 100 mg/day in Patients With Fibromyalgia
    Arnold, Lesley M.
    Gendreau, R. Michael
    Palmer, Robert H.
    Gendreau, Judy F.
    Wang, Yong
    ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2745 - 2756
  • [40] Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate (45 mg/kg per day) for the treatment of uncomplicated acute otitis media
    Block, SL
    Arrieta, A
    Seibel, M
    McLinn, S
    Eppes, S
    Murphy, MJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2003, 64 : A30 - A42